# Dexmedetomidine Versus Hyalase Treatment of Carpal Tunnel Syndrome

> **NCT05280223** · NA · COMPLETED · sponsor: **Assiut University** · enrollment: 60 (actual)

## Conditions studied

- Carpal Tunnel Syndrome
- Pain, Chronic

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Hyalase

## Key facts

- **NCT ID:** NCT05280223
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-08-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05280223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05280223, "Dexmedetomidine Versus Hyalase Treatment of Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05280223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*